Investigating pulmonary blood flow during exercise
Official title: Pulmonary Hemodynamics During Exercise - Research Network
Run by Medical University of Graz · NCT03954574 · Data updated 2026-11-12
This study is testing how blood flow in the lungs during exercise affects the health and outcomes of people with lung circulation problems.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Medical University of Graz Academic / other |
| Locations | 32 sites (Phoenix, Arizona and 31 other locations) |
| Status | Recruiting |
| Started | December 1, 2018 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | April 27, 2025 |
| Trial ID | NCT03954574 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 with intermediate or high echocardiographic probability of pulmonary hypertension and/or unexplained dyspnea.
✕Probably not a fit
Patients with advanced tumor diseases, severe heart failure, or significant respiratory limitations may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical research collaboration aims to explore the prognostic implications of pulmonary hemodynamics during exercise through a large-scale multi-center approach. The study will utilize both retrospective and prospective analyses of hemodynamic data collected from patients undergoing right heart catheterization. By assessing pulmonary blood flow during physical activity, the research seeks to better understand the impact of pulmonary circulation diseases on patient outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved prognostic assessments and treatment strategies for patients with pulmonary circulation diseases.
How similar studies have gone: Other studies have shown promise in understanding pulmonary hemodynamics, but this approach may provide novel insights due to its multi-center design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients (females and males; age: above 18yrs) with intermediate or high echocardiographic probability of PH and/or unexplained dyspnea, and/or associated conditions for PAH as clinical indication for RHC at rest and exercise * Written informed consent of participating subjects after being fully briefed (for prospective analysis) Exclusion Criteria: * Patients with incomplete hemodynamic data at rest or exercise * Patients without sufficient follow-up data (information on survival / lung transplantation) * advanced tumour disease or other diseases with a short life expectancy, except pulmonary vascular diseases * advanced heart failure with pulmonary arterial wedge pressure (PAWP) \> 18 mmHg at rest * uncontrolled systemic arterial hypertension (RR values \> 160/100 mmHg at rest) * FEV1\<50% predicted * TLC\<60% predicted
Where it's running
-
University of Arizona, Banner University Medical Center
Phoenix, Arizona, United States Recruiting -
University of California, Los Angeles, Lung & Heart-Lung Transplant and Pulmonary Hypertension Programs, David Geffen School of Medicine
Los Angeles, California, United States Recruiting -
Johns Hopkins Hospital, Advanced HF, MCS, Transplant Cardiology, Baltimore, Maryland, USA
Baltimore, Maryland, United States Recruiting -
Massachusetts General Hospital, Cardiology Division and Pulmonary Unit
Boston, Massachusetts, United States Recruiting -
Harvard Medical School, Brigham and Women's Hospital
Boston, Massachusetts, United States Recruiting -
University of Minnesota Medical School, Division of Cardiology, Department of Medicine, Lillehei Heart Institute Minneapolis, Minnesota, USA
Minneapolis, Minnesota, United States Recruiting
Show 26 more locations
-
Mayo Clinic, Division of Cardiovascular Diseases, Department of Medicine
Rochester, Minnesota, United States Recruiting -
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting -
Royal Prince Alfred Hospital, Respiratory Medicine
Camperdown, Australia Recruiting -
Medical University of Graz
Graz, Austria Recruiting -
Free University of Brussels, Faculty of Medicine, Physiology
Brussels, Belgium Recruiting -
University of São Paulo Medical School
São Paulo, Brazil Recruiting -
Department of Cardiology, Aarhus University Hospital, Denmark
Aarhus, Denmark Recruiting -
Université de Lorraine
Nancy, France Recruiting -
Centre Chirurgical Marie Lannelongue, Thoracic and Vascular Surgery
Paris, France Recruiting -
Centre de Référence de l'Hypertension Pulmonaire, Université ParisSud - Université Paris-Saclay, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris
Paris, France Recruiting -
Sorbonne Universités, Neurophysiologie respiratoire expérimentale et clinique
Paris, France Recruiting -
University of Cologne, Klinik III fuer Innere Medizin
Cologne, Germany Recruiting -
Justus-Liebig-University Giessen, Department of Internal Medicine
Giessen, Germany Recruiting -
University of Greifswald
Greifswald, Germany Recruiting -
Thorax Clinic Heidelberg, Centre for Pulmonary Hypertension
Heidelberg, Germany Recruiting -
Academic Teaching Hospital of the Julius Maximilian University of Würzburg
Würzburg, Germany Recruiting -
University of Bologna
Bologna, Italy Recruiting -
University of Rome La Sapienza, Cardiovascular and Respiratory Sciences
Roma, Italy Recruiting -
VU Medisch Centrum, Pulmonology
Amsterdam, Netherlands Recruiting -
Otwock Medical Center of Postgraduate Education, Department of Pulmonary Circulation and Thromboembolic Diseases
Otwock, Poland Recruiting -
Barcelona Hospital Clínic, Pneumologia
Barcelona, Spain Recruiting -
University Hospital of Zurich, Internal Medicine
Zurich, Switzerland Recruiting -
Scottish Pulmonary Vascular Unit
Glasgow, United Kingdom Recruiting -
Imperial College, NHS Healthcare NHS Trust, National Pulmonary Hypertension Service
London, United Kingdom Recruiting -
Royal Brompton Hospital
London, United Kingdom Recruiting -
Royal Hallamshire Hospital, Sheffield Pulmonary Vascular Disease Unit
Sheffield, United Kingdom Recruiting
Study contacts
- Study coordinator: Gabor Kovacs, MD
- Email: gabor.kovacs@klinikum-graz.at
- Phone: +43-316-385
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bioresorbable Magnesium Screws for Ankle Syndesmotic Injuries: A First Look
This pilot study tests whether a bioresorbable magnesium screw can safely fix ankle syndesmotic injuries in adults with isolated injuries or small fracture patterns.
-
Agreement between non-invasive cuff and arterial line BP during anesthesia induction
This study tests whether blood pressure readings from an automated upper-arm cuff align with continuous arterial line measurements in high-risk patients starting general anesthesia.
-
Point-of-Care Test for Early Infection Signs in Preterm Babies
This pilot observational study will see if a rapid point-of-care blood test can help detect early signs of infection in preterm infants and compare its results with standard lab tests.
-
Continuous body-temperature monitoring of preterm babies after birth using a wireless adhesive thermometer
This study tests whether a wireless, adhesive thermometer can continuously monitor temperature in preterm neonates during the first 15 minutes after birth.
-
Continuous skin temperature monitoring in newborns during therapeutic hypothermia
This study tests whether a wireless adhesive thermometer can safely and accurately monitor temperature in term and near-term newborns receiving therapeutic cooling.
-
Transfusion-Related Changes in Oxidative Stress Markers in Newborns
This study tests whether red blood cell transfusions and oxygen therapy affect oxidative stress markers in newborns, especially extremely preterm babies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.